BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21290429)

  • 1. NMR QSAR model for the analysis of 4-(5-arylamino-1,3,4-thiadiazol-2-yl)benzene-1,3-diols.
    Matysiak J; Niewiadomy A; Paw B; Dybała I
    Arch Pharm (Weinheim); 2011 May; 344(5):340-4. PubMed ID: 21290429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of electronic, lipophilic and membrane affinity effects on antiproliferative activity of 5-substituted-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles against various human cancer cells.
    Matysiak J
    Eur J Med Chem; 2007 Jul; 42(7):940-7. PubMed ID: 17320247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
    Matysiak J; Nasulewicz A; Pełczyńska M; Switalska M; Jaroszewicz I; Opolski A
    Eur J Med Chem; 2006 Apr; 41(4):475-82. PubMed ID: 16517026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR models of antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazoles in various cancer cell lines.
    Matysiak J; Niewiadomy A
    Mol Divers; 2017 Feb; 21(1):211-218. PubMed ID: 27722985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
    Matysiak J; Opolski A
    Bioorg Med Chem; 2006 Jul; 14(13):4483-9. PubMed ID: 16517170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b][1,3,4]-thiadiazole derivatives.
    Noolvi MN; Patel HM; Singh N; Gadad AK; Cameotra SS; Badiger A
    Eur J Med Chem; 2011 Sep; 46(9):4411-8. PubMed ID: 21820217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
    Kumar D; Maruthi Kumar N; Chang KH; Shah K
    Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
    Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
    Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activity of a novel class of flavonoids: 2,4-diarylchromane[4,3-d]-delta(1,9b)-1,2,3-thiadiazolines.
    Ying H; Hu Y; He Q; Li R; Yang B
    Eur J Med Chem; 2007 Feb; 42(2):226-34. PubMed ID: 17137679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles.
    Kumar D; Kumar NM; Chang KH; Gupta R; Shah K
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-pot synthesis of new (1,3-thiazolo[5,4-b]pyridin-2-yl)benzenediols and their antiproliferative activities against human cancer cell lines.
    Matysiak J; Karpińska MM; Niewiadomy A; Wietrzyk J; Kłopotowska D
    Chem Biodivers; 2012 Jan; 9(1):48-57. PubMed ID: 22253102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
    Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and QSAR study of analogs of alpha-tocopherol with enhanced antiproliferative activity against human breast adenocarcinoma cells.
    Nikolic KM
    J Mol Graph Model; 2008 Jan; 26(5):868-73. PubMed ID: 17616411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 5-formyl-6-arylimidazo(2,1-b)-1,3,4-thiadiazole-2-N-(dimethylaminomethi no) sulfonamides as antitumor agents.
    Gadad AK; Karki SS; Rajurkar VG; Bhongade BA
    Arzneimittelforschung; 1999 Oct; 49(10):858-63. PubMed ID: 10554665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
    Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
    Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
    Hayat F; Salahuddin A; Zargan J; Azam A
    Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
    Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
    Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
    Nikolic K; Agababa D
    J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
    Revelant G; Gadais C; Mathieu V; Kirsch G; Hesse S
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2724-7. PubMed ID: 24815511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor-evaluation of 1,3,4-thiadiazole-containing benzisoselenazolone derivatives.
    Luo Z; Chen B; He S; Shi Y; Liu Y; Li C
    Bioorg Med Chem Lett; 2012 May; 22(9):3191-3. PubMed ID: 22483583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.